[Segreteria.iii] GUIDE-AI Update: Grant Preparation & Next Steps
Donato Gualtieri
donato.gualtieri a unipv.it
Gio 27 Nov 2025 09:20:54 CET
Ciao Enea,
hanno accolto la nostra richiesta riguardo alla liability.
Non quella sulla Joint Ownership ma il meglio è nemico del bene, quindi
direi che per noi si può chiudere così.
Nota che a pag. 15 c'è un commento a cui chiedono espressamente risposta a
te.
Per il resto ho solo aggiunto Sofia e la UOC come contatti amministrativi.
Se non ci sono ulteriori modifiche il Direttore può firmare non appena
avrete la versione definitiva.
A presto
Donato
Il giorno mer 26 nov 2025 alle ore 14:42 Enea Parimbelli <
enea.parimbelli a gmail.com> ha scritto:
> Cari tutti,
> vi ringrazio per i vari feedback sul Consortium Agreement, che sono stati
> integrati dai colleghi che coordinano il consorzio.
> Allego la versione attuale "pulita" (pending alcuni punti che si stanno
> chiarendo in queste ore).
>
> IMPORTANTE: con questa mail avvertirei anche i firmatari (il nostro
> direttore @Paolo Di Barba <paolo.dibarba a unipv.it> a quanto ho capito e'
> sufficiente) di tenersi pronti a una firma molto veloce, da perfezionare
> entro la prossima settimana.
>
> la ragione e' che, per iniziare il progetto il 1o Gennaio 2026 come ci
> siamo prefissati, il grant agreement vada firmato entro l'8 Dicembre, per
> lasciare alla Commissione Europea poi le canoniche 2 settimane per rivedere
> il tutto e controfirmare.
>
> In breve, il processo:
> 1) entro questa settimana chiederanno di rilasciare il GA per firma del
> coordinatore (Charite')
> 2) a valle di quello anche tutti gli altri partner, UNIPV inclusa,
> dovranno firmare il GA --> scadenza 8 Dicembre
> 3) la European Commission avra' 2 settimane per rivedere il documento e
> dare final approval
> 4) partenza ufficiale progetto 1 Gennaio 2026
>
> Grazie e a presto,
> Enea
>
> Il giorno mar 21 ott 2025 alle ore 15:43 Donato Gualtieri <
> donato.gualtieri a unipv.it> ha scritto:
>
>> Ciao Enea,
>> in allegato il CA rivisto. Consiglio di sottoporre le questioni relative
>> alla gestione dei dati alla UOC Privacy (privacy a unipv.it), specie per
>> l'art. 4 e l'allegato 3.
>> Per il resto c'è una richiesta relativa alla Joint Ownership
>> (preferiremmo l'opzione 1 ma va bene anche la 2). Il punto delicato
>> riguarda l'art.12.6 in cui si fissa il limite della *liability *a 1
>> milione di euro o al doppio del finanziamento ricevuto. Per un ente
>> pubblico, almeno in Italia, questa clausola non è accettabile e rischia di
>> essere un dealbreaker.
>>
>> Fammi sapere se posso fare altro.
>> A presto
>> Donato
>>
>> Il giorno mer 15 ott 2025 alle ore 10:19 Donato Gualtieri <
>> donato.gualtieri a unipv.it> ha scritto:
>>
>>> Grazie a te,
>>> analizziamo il documento e ti diamo un feedback entro la deadline.
>>> A presto
>>> Donato
>>>
>>> Il giorno mar 14 ott 2025 alle ore 17:45 Enea Parimbelli <
>>> enea.parimbelli a gmail.com> ha scritto:
>>>
>>>> Caro Donato, tutti
>>>> allego lo zip dei file condivisi, per vostra revisione.
>>>> Grazie della precisazione sul firmatario. A questo punto approccio il
>>>> nostro direttore di dipartimento
>>>> Attendo vostro feedback entro fine mese sui documenti cosi' da
>>>> inoltrarlo ai coordinatori
>>>>
>>>> Enea
>>>>
>>>> Il giorno gio 9 ott 2025 alle ore 12:17 Donato Gualtieri <
>>>> donato.gualtieri a unipv.it> ha scritto:
>>>>
>>>>> Buongiorno Enea,
>>>>>
>>>>> non abbiamo accesso al cloud di AZ, quindi ti chiediamo gentilmente di
>>>>> girarci il file da rivedere. Trattandosi di accordo di ricerca non è
>>>>> necessario, salvo casi specifici, coinvolgere altri uffici.
>>>>> In teoria il firmatario dei CA nei progetti Horizon Europe è il
>>>>> Direttore del Dipartimento coinvolto.
>>>>> Buona giornata e a presto
>>>>> Donato
>>>>>
>>>>> Il giorno gio 9 ott 2025 alle ore 10:35 Enea Parimbelli <
>>>>> enea.parimbelli a gmail.com> ha scritto:
>>>>>
>>>>>> Buongiorno Andrea, Donato e colleghi dell'ufficio ricerca
>>>>>> per il grant IHI GUIDE-AI il partner industriale AstraZeneca, in
>>>>>> concerto col coordinatore Charite Berlino, hanno prodotto una prima
>>>>>> versione del consortium agreement, che ci chiedono di controllare e su cui
>>>>>> eventualmente dare feedback. Chiedendo a @Silvana Quaglini
>>>>>> <silvana.quaglini a unipv.it> data la sua esperienza recente con
>>>>>> CAPABLE mi ha suggerito di passare da voi.
>>>>>>
>>>>>> Sotto la mail della collega coi dettagli. In particolare, *entro
>>>>>> fine mese*, vi chiederei di 1) leggere il CA e coinvolgere i
>>>>>> colleghi che ritenete opportuno (ufficio legale?), 2) confermare che
>>>>>> l'unico signatory del documento lato unipv sara' il Rettore Alessandro
>>>>>> Reali, come ho gia' indicato nell'excel nella cartella condivisa. Alcune
>>>>>> istituzioni ho appreso che richiedono 2 firmatari ma non so se e' il nostro
>>>>>> caso
>>>>>>
>>>>>> Vi ringrazio se mi date un feedback, o ci tenete in copia se
>>>>>> interagite direttamente coi colleghi Laura Paulowski (AZ, project
>>>>>> management) e Matthias Groeschel (Charite, PI scientifico)
>>>>>>
>>>>>> Grazie e a presto
>>>>>> Enea
>>>>>>
>>>>>> ---------- Forwarded message ---------
>>>>>> Da: Paulowski, Laura <laura.paulowski a astrazeneca.com>
>>>>>> Date: gio 2 ott 2025 alle ore 17:21
>>>>>> Subject: GUIDE-AI Update: Grant Preparation & Next Steps
>>>>>> To: Leif-Erik Sander <leif-erik.sander a charite.de>, Witzenrath,
>>>>>> Martin <martin.witzenrath a charite.de>, Mittermaier, Mirja <
>>>>>> mirja.mittermaier a charite.de>, Eckardt, Kai-Uwe <
>>>>>> kai-uwe.eckardt a charite.de>, Röschl, Tobias <
>>>>>> tobias.roeschl a dhzc-charite.de>, Röschl, Florian <
>>>>>> florian.roeschl a charite.de>, Meyer, Alexander <
>>>>>> alexander.meyer a dhzc-charite.de>, Firsching, Anja <
>>>>>> anja.firsching a charite.de>, Richter, Katharina <
>>>>>> katharina.richter a charite.de>, Stobäus, Nicole <
>>>>>> nicole.stobaeus a charite.de>, andrea.passantino a icsmaugeri.it <
>>>>>> andrea.passantino a icsmaugeri.it>, Gogluska-Obirek, Marta <
>>>>>> marta.obirek a charite.de>, Fischer, Ronny <ronny.fischer a charite.de>,
>>>>>> Vitacca Michele <michele.vitacca a icsmaugeri.it>, Lucia Sacchi <
>>>>>> lucia.sacchi a unipv.it>, Spanevello Antonio <
>>>>>> antonio.spanevello a icsmaugeri.it>, Napolitano Carlo <
>>>>>> carlo.napolitano a icsmaugeri.it>, Grant Office <
>>>>>> grantoffice a icsmaugeri.it>, Ceriana Piero <
>>>>>> piero.ceriana a icsmaugeri.it>, Riccardo Bellazzi <
>>>>>> riccardo.bellazzi a unipv.it>, Brunati Valentina <
>>>>>> valentina.brunati a icsmaugeri.it>, Akkerman, OW (long) <
>>>>>> o.w.akkerman a umcg.nl>, Fraterman, I (onco) <i.fraterman a umcg.nl>,
>>>>>> X:m.van.den.berge <m.van.den.berge a umcg.nl>, Gregor Štiglic <
>>>>>> gregor.stiglic a um.si>, Martin Michalowski <martinm a umn.edu>, Alan
>>>>>> Altraja <alan.altraja a ut.ee>, Felix Mühlensiepen <
>>>>>> Felix.Muehlensiepen a mhb-fontane.de>, Defosse, Kerstin <
>>>>>> kerstin.defosse a astrazeneca.com>, Seewald, Michael <
>>>>>> michael.seewald a astrazeneca.com>, Cavlar, Taner <
>>>>>> taner.cavlar a takeda.com>, Jana Hassel <Jana.Hassel a bag-selbsthilfe.de>,
>>>>>> Florian Streckert <florian.streckert a bag-selbsthilfe.de>, Tobias
>>>>>> Hastenteufel <tobias.hastenteufel a qurasoft.de>, Diana Klich <
>>>>>> diana.klich a qurasoft.de>, Schmerbach, Kristin <
>>>>>> kristin.schmerbach a takeda.com>, Artur Schens <
>>>>>> artur.schens a qurasoft.de>, Piper, Edward <
>>>>>> Edward.Piper a astrazeneca.com>, Fenici, Peter <
>>>>>> Peter.Fenici a astrazeneca.com>, Marco Wendel <marco.x.wendel a gsk.com>,
>>>>>> Marie Nielsen <marie.c.nielsen a gsk.com>
>>>>>> Cc: Gröschel, Matthias <matthias.groeschel a charite.de>, Enea
>>>>>> Parimbelli <enea.parimbelli a gmail.com>, Esposito Ciro <
>>>>>> ciro.esposito a icsmaugeri.it>, Tibollo Valentina <
>>>>>> valentina.tibollo a icsmaugeri.it>, Otani, Akiko <
>>>>>> akiko.otani a takeda.com>, d.quaggia a cittadinanzattiva.it <
>>>>>> d.quaggia a cittadinanzattiva.it>, Hendrik Schulze Bröring <
>>>>>> h.s.broering a ecodynamics.de>, Hamidreza Hosseini <
>>>>>> h.hosseini a ecodynamics.de>, Stefania Kalinska <
>>>>>> s.kalinska a ecodynamics.de>, RBalicer a clalit.org.il <
>>>>>> rbalicer a clalit.org.il>, Matthias Diessel <Matthias.x.Diessel a gsk.com
>>>>>> >
>>>>>>
>>>>>>
>>>>>> Dear All,
>>>>>>
>>>>>>
>>>>>>
>>>>>> We are delighted to share that GUIDE-AI has reached an important
>>>>>> milestone: the *Declaration of Honour (DoH) signatures were
>>>>>> successfully completed* by end of September. With this achievement,
>>>>>> we are still on track in the Grant Preparation Phase and can now turn our
>>>>>> attention to the next key steps.
>>>>>>
>>>>>>
>>>>>>
>>>>>> Updates:
>>>>>>
>>>>>> 1. *Consortium Agreement (CA):* A draft version of the CA will be
>>>>>> available shortly on our GUIDE-AI Team in Teams (Info-Sharing |
>>>>>> IHI Call 9 | Microsoft Teams
>>>>>> <https://teams.microsoft.com/l/channel/19%3Av7k1G2vz5umz1bABNNS03KJV_uYqRF3U1K67Uv0sJ8s1%40thread.tacv2/Info-Sharing?groupId=771e3c3b-f8ce-4dbe-ad72-9c6f02f9b225&tenantId=af8e89a3-d9ac-422f-ad06-cc4eb4214314>).
>>>>>> We kindly ask all partners to review and provide feedback until *03
>>>>>> November* to ensure alignment and timely finalization. In
>>>>>> addition, we will share an Excel sheet where each partner is asked to
>>>>>> indicate:
>>>>>> 1. *Who *in their organization needs to sign the CA
>>>>>> 2. Whether you have *one or two signatories*
>>>>>> 2. *Independent Ethics Board:* We followed the recommendation by
>>>>>> IHI as given in the Ethics summary report on installing an independent
>>>>>> Ethics Board for GUIDE-AI.
>>>>>> 3. *IHI SOFIApplication:* Submission of the participants’
>>>>>> profiles and health priority completed.
>>>>>> 4. *Third-Party Participation:* We have received expressions of
>>>>>> interest from third parties willing to join the project at their own cost
>>>>>> and with their own resources. Their potential contributions will be
>>>>>> reviewed in line with the project’s objectives. A joint decision will then
>>>>>> be taken together.
>>>>>> 5. *Partner Update:* One partner has formally dropped out of the
>>>>>> project. However, there remains the possibility of rejoining in Q2-2026.
>>>>>> Continuity of responsibilities is secured and our EU project officer is
>>>>>> aware.
>>>>>> 6. *Project Documentation & Teams Folder:* We will continue to
>>>>>> use our Teams folder (see link above) as the central working space. All
>>>>>> project proposal preparation materials will be moved into a dedicated
>>>>>> Archive folder for reference, while grant preparation and implementation
>>>>>> documents will remain in the active structure.
>>>>>>
>>>>>> à Each partner is kindly asked to check whether all colleagues
>>>>>> involved in GUIDE-AI have access to the Teams folder and are included in
>>>>>> the consortium mailing distribution list. If not, please inform us
>>>>>> of any updates or additions via direct mail so we can ensure
>>>>>> everyone is connected.
>>>>>>
>>>>>>
>>>>>>
>>>>>> *Key Actions required:*
>>>>>>
>>>>>> - Prepare to review the CA once available on Teams
>>>>>> - Complete Excel sheet on CA signatories once available on Teams
>>>>>> - Verify that all relevant colleagues have Teams access and are
>>>>>> on the mailing list
>>>>>> - Continue to use the Teams folder as the main collaboration
>>>>>> platform
>>>>>>
>>>>>>
>>>>>>
>>>>>> Thank you all. If anything is unclear or if you have questions,
>>>>>> please do not hesitate to drop us an email.
>>>>>>
>>>>>>
>>>>>>
>>>>>> Best regards,
>>>>>>
>>>>>> Matthias & Laura
>>>>>>
>>>>>>
>>>>>>
>>>>>> *Dr. Laura Paulowski **(she/her)*
>>>>>>
>>>>>> Medical Innovation Manager
>>>>>>
>>>>>>
>>>>>>
>>>>>>
>>>>>>
>>>>>> *AstraZeneca GmbH*
>>>>>>
>>>>>> Friesenweg 26, 22763 Hamburg
>>>>>>
>>>>>> M: +49 (0)173 1736769
>>>>>>
>>>>>> laura.paulowski a astrazeneca.com
>>>>>>
>>>>>>
>>>>>>
>>>>>> Geschäftsführerin: Alexandra Bishop
>>>>>>
>>>>>> Vorsitzender des Aufsichtsrates: Eduardo Kneese
>>>>>>
>>>>>> Handelsregister: Hamburg HRB 175066
>>>>>>
>>>>>> www.astrazeneca.de
>>>>>> www.astrazeneca.com
>>>>>>
>>>>>>
>>>>>> <https://www.linkedin.com/company/astrazeneca/mycompany/verification/>
>>>>>> <https://www.instagram.com/astrazeneca_germany/>
>>>>>>
>>>>>>
>>>>>>
>>>>>>
>>>>>>
>>>>>> *Confidentiality Notice: *This message is private and may contain
>>>>>> confidential and proprietary information. If you have received this message
>>>>>> in error, please notify us and remove it from your system and note that you
>>>>>> must not copy, distribute or take any action in reliance on it. Any
>>>>>> unauthorized use or disclosure of the contents of this message is not
>>>>>> permitted and may be unlawful. *D**ata privacy information:
>>>>>> <https://www.astrazeneca.de/datenschutzbestimmungen.html>https://www.astrazeneca.de/dataprivacy.html
>>>>>> <https://www.astrazeneca.de/datenschutzbestimmungen.html>
>>>>>> <https://www.astrazeneca.de/datenschutzbestimmungen.html> *
>>>>>>
>>>>>>
>>>>>> --
>>>>>> *Enea Parimbelli, Ph.D.*
>>>>>> Assistant professor
>>>>>> Department of Electrical, Computer and Biomedical Engineering
>>>>>>
>>>>>> University of Pavia
>>>>>> Via A. Ferrata 5 - 27100 Pavia
>>>>>> NOTE: I work flexibly at UNIPV. If this email reaches you outside
>>>>>> your working hours, please respond when it best fits your schedule.
>>>>>>
>>>>>
>>>>>
>>>>> --
>>>>>
>>>>>
>>>>> [image: LOGO-UNIPV]
>>>>> Donato Gualtieri, PhD
>>>>> Servizio Ricerca e Formazione alla Ricerca
>>>>> U.O.C. Progettazione e Gestione Ricerca
>>>>> Strada Nuova, 65 - 27100 Pavia (Italia)
>>>>> <http://maps.google.com/?q=Strada+Nuova%2C+65+27100+Pavia+%28Italia%29>
>>>>> T. 0382984987
>>>>>
>>>>>
>>>>>
>>>>>
>>>>>
>>>>
>>>> --
>>>> *Enea Parimbelli, Ph.D.*
>>>> Assistant professor
>>>> Department of Electrical, Computer and Biomedical Engineering
>>>>
>>>> University of Pavia
>>>> Via A. Ferrata 5 - 27100 Pavia
>>>> NOTE: I work flexibly at UNIPV. If this email reaches you outside your
>>>> working hours, please respond when it best fits your schedule.
>>>>
>>>
>>>
>>> --
>>>
>>>
>>> [image: LOGO-UNIPV]
>>> Donato Gualtieri, PhD
>>> Servizio Ricerca e Formazione alla Ricerca
>>> U.O.C. Progettazione e Gestione Ricerca
>>> Strada Nuova, 65 - 27100 Pavia (Italia)
>>> <http://maps.google.com/?q=Strada+Nuova%2C+65+27100+Pavia+%28Italia%29>
>>> T. 0382984987
>>>
>>>
>>>
>>>
>>>
>>
>> --
>>
>>
>> [image: LOGO-UNIPV]
>> Donato Gualtieri, PhD
>> Servizio Ricerca e Formazione alla Ricerca
>> U.O.C. Progettazione e Gestione Ricerca
>> Strada Nuova, 65 - 27100 Pavia (Italia)
>> <http://maps.google.com/?q=Strada+Nuova%2C+65+27100+Pavia+%28Italia%29>
>> T. 0382984987
>>
>>
>>
>>
>>
>
> --
> *Enea Parimbelli, Ph.D.*
> Assistant professor
> Department of Electrical, Computer and Biomedical Engineering
>
> University of Pavia
> Via A. Ferrata 5 - 27100 Pavia
> NOTE: I work flexibly at UNIPV. If this email reaches you outside your
> working hours, please respond when it best fits your schedule.
>
--
[image: LOGO-UNIPV]
Donato Gualtieri, PhD
Servizio Ricerca e Formazione alla Ricerca
U.O.C. Progettazione e Gestione Ricerca
Strada Nuova, 65 - 27100 Pavia (Italia)
<http://maps.google.com/?q=Strada+Nuova%2C+65+27100+Pavia+%28Italia%29>
T. 0382984987
-------------- parte successiva --------------
Un allegato HTML è stato rimosso...
URL: http://ipv01.unipv.it/cgi-bin/mailman/private/segreteria.iii/attachments/20251127/0f68cc0d/attachment-0001.htm
-------------- parte successiva --------------
Un allegato non testuale è stato rimosso....
Nome: image001.gif
Tipo: image/gif
Dimensione: 1088 bytes
Descrizione: non disponibile
Url: http://ipv01.unipv.it/cgi-bin/mailman/private/segreteria.iii/attachments/20251127/0f68cc0d/attachment-0003.gif
-------------- parte successiva --------------
Un allegato non testuale è stato rimosso....
Nome: image002.png
Tipo: image/png
Dimensione: 3489 bytes
Descrizione: non disponibile
Url: http://ipv01.unipv.it/cgi-bin/mailman/private/segreteria.iii/attachments/20251127/0f68cc0d/attachment-0001.png
-------------- parte successiva --------------
Un allegato non testuale è stato rimosso....
Nome: image003.gif
Tipo: image/gif
Dimensione: 29630 bytes
Descrizione: non disponibile
Url: http://ipv01.unipv.it/cgi-bin/mailman/private/segreteria.iii/attachments/20251127/0f68cc0d/attachment-0004.gif
-------------- parte successiva --------------
Un allegato non testuale è stato rimosso....
Nome: image004.gif
Tipo: image/gif
Dimensione: 31948 bytes
Descrizione: non disponibile
Url: http://ipv01.unipv.it/cgi-bin/mailman/private/segreteria.iii/attachments/20251127/0f68cc0d/attachment-0005.gif
-------------- parte successiva --------------
Un allegato non testuale è stato rimosso....
Nome: GUIDE-AI_Project-ID_101253015_CA_copy_Maugeri_UNIPV.docx
Tipo: application/vnd.openxmlformats-officedocument.wordprocessingml.document
Dimensione: 321952 bytes
Descrizione: non disponibile
Url: http://ipv01.unipv.it/cgi-bin/mailman/private/segreteria.iii/attachments/20251127/0f68cc0d/attachment-0001.bin
Maggiori informazioni sulla lista
Segreteria.iii